SCHEMBL21382964

SCHEMBL21382964

Cc1cc(C(=O)Nc2ccc(CN3CCN(C)CC3)cc2)ccc1NC(=O)CCl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.60
NPC1 O15118 2/20 0.60
ALDH1A1 P00352 2/20 0.60
BTK Q06187 1/20 0.55
KIT P10721 6/20 0.54
DDR2 Q16832 2/20 0.54
HDAC6 Q9UBN7 1/20 0.51
ABL1 P00519 4/20 0.49
MAPK14 Q16539 4/20 0.49
LCK P06239 4/20 0.49
CSF1R P07333 4/20 0.49
BCR P11274 2/20 0.49
EGFR P00533 2/20 0.49
KDR P35968 2/20 0.49
ERBB4 Q15303 1/20 0.49
PLK4 O00444 1/20 0.49
DDX3X O00571 1/20 0.49
GAK O14976 1/20 0.49
SLC22A2 O15244 1/20 0.49
MAPK13 O15264 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21400972 0.86 NPC1 (0.79) RAB9ANPC1ALDH1A1BTKKIT
SCHEMBL22958866 0.81 RAB9A (0.62) RAB9ANPC1ALDH1A1BTKKIT
SCHEMBL22529530 0.81 KIT (0.68) RAB9ANPC1ALDH1A1BTKKIT
SCHEMBL14409556 0.80 SMN1; SMN2 (0.67) RAB9ANPC1ALDH1A1BTKHDAC6
SCHEMBL13747820 0.80 SMN1; SMN2 (0.67) RAB9ANPC1ALDH1A1BTKHDAC6
SCHEMBL15381992 0.79 BTK (0.69) RAB9ANPC1ALDH1A1BTKKIT
SCHEMBL12345537 0.79 NPC1 (0.62) RAB9ANPC1ALDH1A1BTKKIT
SCHEMBL21400969 0.78 RAB9A (0.66) RAB9ANPC1ALDH1A1BTKKIT
SCHEMBL16755297 0.78 KIT (0.70) RAB9ANPC1ALDH1A1BTKKIT
SCHEMBL24024030 0.77 RAB9A (0.73) RAB9ANPC1ALDH1A1BTKHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768682-A1 NOVEL KINASE INHIBITORS EXHIBITING ANTI-CANCER ACTIVITY AND THEIR METHOD OF USE Allcron Pharma Inc. (US) 2021-01-27 EP disclosed
WO-2019182944-A1 NOVEL KINASE INHIBITORS EXHIBITING ANTI-CANCER ACTIVITY AND THEIR METHOD OF USE ALLCRON PHARMA INC. (US) 2019-09-26 WO disclosed